---
title: "CE mark trial of Optimum TAVI valve given green light for expansion"
date: "2023-12-18T09:55:28.000Z"
publishedDate: "18 décembre 2023"
summary: "Thubrikar Aortic Valve has received authorisation from the Competent Authority of Poland to expand the TAVI-1 CE mark trial of the Optimum transcatheter aortic valve implantation (TAVI) system. The authorisation allows for an additional 15 patients to be treated with the Optimum TAV using the Company’s second-generation delivery catheter, the Precision 2 catheter."
importance: ""
sourceUrl: "https://cardiovascularnews.com/ce-mark-trial-of-optimum-tavi-valve-given-green-light-for-expansion/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2023-12-18-ce-mark-trial-of-optimum-tavi-valve-given-green-light-for-expansion"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2022/08/Thubrikar-AV.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/ce-mark-trial-of-optimum-tavi-valve-given-green-light-for-expansion/"
---

![CE mark trial of Optimum TAVI valve given green light for expansion](https://cardiovascularnews.com/wp-content/uploads/sites/14/2022/08/Thubrikar-AV.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/ce-mark-trial-of-optimum-tavi-valve-given-green-light-for-expansion/*

## L’essentiel

Thubrikar Aortic Valve has received authorisation from the Competent Authority of Poland to expand the TAVI-1 CE mark trial of the Optimum transcatheter aortic valve implantation (TAVI) system. The authorisation allows for an additional 15 patients to be treated with the Optimum TAV using the Company’s second-generation delivery catheter, the Precision 2 catheter.

## Lien source

https://cardiovascularnews.com/ce-mark-trial-of-optimum-tavi-valve-given-green-light-for-expansion/
